DIVIS LABORATORIES
Back to Cashflow Statement
|
DIVIS LABORATORIES Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-2,219 Cr | ₹-804 Cr | ₹-269 Cr | ₹-2,707 Cr | ₹-2,195 Cr |
What is the latest Cash Flow from Investing Activities ratio of DIVIS LABORATORIES ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2026 | ₹-2,219 Cr |
| Mar2025 | ₹-804 Cr |
| Mar2024 | ₹-269 Cr |
| Mar2023 | ₹-2,707 Cr |
| Mar2022 | ₹-2,195 Cr |
How is Cash Flow from Investing Activities of DIVIS LABORATORIES Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-2,219 Cr | Negative | |
| Mar2025 | ₹-804 Cr | Negative | |
| Mar2024 | ₹-269 Cr | Negative | |
| Mar2023 | ₹-2,707 Cr | Negative | |
| Mar2022 | ₹-2,195 Cr | - | |
Compare Cash Flow from Investing Activities of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹226,657.4 Cr | 2.2% | 23.1% | 27.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,471.0 Cr | -0.5% | 0.8% | 19% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,157.0 Cr | -2.6% | -1.6% | 36% | Stock Analytics | |
| CIPLA | ₹118,108.0 Cr | 0.8% | 2.5% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,578.0 Cr | 2.6% | -2.4% | -5.6% | Stock Analytics | |
| MANKIND PHARMA | ₹100,152.0 Cr | -1.1% | -3.4% | -7.2% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 2.2% |
23.1% |
27.4% |
| SENSEX | -0.4% |
0.8% |
-3% |
You may also like the below Video Courses